Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne M V Huizing

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|March 30, 2021
Discordant Uptake Between Diagnostic 68Ga-HA-DOTATATE PET/CT and Posttherapy 177Lu-HA-DOTATATE SPECT/CT in Patients With Neuroendocrine TumorsDaphne M V Huizing, Else A Aalbersberg, Bernies van der Hiel, et al.
Journal of Applied Clinical Medical Physics|August 14, 2020
<sup>177</sup> Lutetium SPECT/CT: Evaluation of collimator, photopeak and scatter correctionDaphne M V Huizing, Michiel Sinaasappel, Marien C Dekker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 PatientsElse A Aalbersberg, Daphne M V Huizing, Iris Walraven, et al.
EJNMMI Physics|June 4, 2020
A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapyDaphne M V Huizing, Steffie M B Peters, Michelle W J Versleijen, et al.
EJNMMI Physics|November 10, 2019
Multicentre quantitative <sup>68</sup>Ga PET/CT performance harmonisationDaphne M V Huizing, Daniëlle Koopman, Jorn A van Dalen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 12, 2020
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapyDaphne M V Huizing, Else A Aalbersberg, Michelle W J Versleijen, et al.
European Urology Focus|February 24, 2020
State-of-the-art Intraoperative Imaging Technologies for Prostate Margin Assessment: A Systematic ReviewJudith Olde Heuvel, Berlind J de Wit-van der Veen, Daphne M V Huizing, et al.
Current Oncology Reports|April 10, 2024
Advances in Radionuclide Therapies for Patients with Neuro-endocrine TumorsDenise S Hoogenkamp, Linda J de Wit-van der Veen, Daphne M V Huizing, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|March 30, 2021
Discordant Uptake Between Diagnostic 68Ga-HA-DOTATATE PET/CT and Posttherapy 177Lu-HA-DOTATATE SPECT/CT in Patients With Neuroendocrine TumorsDaphne M V Huizing, Else A Aalbersberg, Bernies van der Hiel, et al.
Journal of Applied Clinical Medical Physics|August 14, 2020
<sup>177</sup> Lutetium SPECT/CT: Evaluation of collimator, photopeak and scatter correctionDaphne M V Huizing, Michiel Sinaasappel, Marien C Dekker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 PatientsElse A Aalbersberg, Daphne M V Huizing, Iris Walraven, et al.
EJNMMI Physics|June 4, 2020
A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapyDaphne M V Huizing, Steffie M B Peters, Michelle W J Versleijen, et al.
EJNMMI Physics|November 10, 2019
Multicentre quantitative <sup>68</sup>Ga PET/CT performance harmonisationDaphne M V Huizing, Daniëlle Koopman, Jorn A van Dalen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 12, 2020
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapyDaphne M V Huizing, Else A Aalbersberg, Michelle W J Versleijen, et al.
European Urology Focus|February 24, 2020
State-of-the-art Intraoperative Imaging Technologies for Prostate Margin Assessment: A Systematic ReviewJudith Olde Heuvel, Berlind J de Wit-van der Veen, Daphne M V Huizing, et al.
Current Oncology Reports|April 10, 2024
Advances in Radionuclide Therapies for Patients with Neuro-endocrine TumorsDenise S Hoogenkamp, Linda J de Wit-van der Veen, Daphne M V Huizing, et al.
Pageof 1